MGAT5 and neoplasm: Given that our standard injection approach resulted in Mgat5-KO tumors that were too small for immune profiling (even at the point of maximal size; 12 days), 10-fold more tumor cells (2 × 106) were injected into C57BL/6 mice to obtain tumors that would be adequate for flow cytometry.